SBIR/STTR Research Award
MOLECULAR CLONING AND EXPRESSION OF HUMAN ANTI-GP12
Award amount
$50,000Program and phase
SBIR · Phase IAward year
1991Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- IDEC PHARMACEUTICALS CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
ANTIBODIES CAN BE FOUND IN THE SERA OF HIV SEROPOSITIVPARTICULAR, ANTIBODIES ARE PRESENT WHICH ARE REACTIVE AGAINST VARIOUS EPITOPES OF THE HIV ENVELOPE PROTEIN GP120. MANY OF THESE ARE STRAIN SPECIFIC AND REACT WITH HYPERVARIABLE DOMAINS, WHILE OTHERS, PRESENT AT LOWER LEVELS, ARE DIRECTED AGAINST THE CD4 BINDING SITE, NEUTRALIZE VIRAL INFECTIVITY AND ARE GROUP-SPECIFIC. THE INTENT HERE IS TO CLONE IMMUNOGLOBULIN GENES FROM SINGLE B CELLS WHICH EXPRESS THE LATTER TYPE OF ANTIBODY, AFTER THEY HAVE BEEN EXPANDED IN VITRO. USING POLYMERASE CHAIN REACTION (PCR) TECHNIQUES, VARIABLE REGION IMMUNOGLOBULIN GENES WILL BE AMPLIFIED AND CLONED INTO AMPLIFIABLE MAMMALIAN EXPRESSION VECTORS WHICH CONTAIN HUMAN HEAVY AND LIGHT CHAIN CONSTANT REGION GENES. HUMAN ANTIBODIES OF THE DESIRED ISOTYPE WILL BE SECRETED IN CHINESE HAMSTER OVARY (CHO) AND MOUSE MYELOMA (SP2/0) CELL LINES, USING A HIGH EFFICIENCY AMPLIFIABLE EXPRESSION SYSTEM. THE ANTIBODIES PRODUCED WILL BE USED IN AIDS THERAPY, AND THE TECHNIQUES THAT ARE DEVELOPED APPLIED TO OTHER ANTIBODIES FOR FUTURE USE IN VARIOUS HUMAN DISEASES.
Technology keywords
Not reported